Article Details
Retrieved on: 2024-10-24 16:16:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Anti-amyloid beta (Aβ) monoclonal antibody (mAb) donanemab is part of new class of amyloid targeting therapies, and while it can slow Alzheimer's ...
Article found on: www.europeanpharmaceuticalreview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here